ReviewFrontiers in immunology2026

The impact of obesity-related systemic inflammation on the efficacy, toxicity, and biomarkers of immune checkpoint inhibitors in lung cancer: from mechanisms to clinical management.

Yewei Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.